StopDown
Ayati Devices logo
Funding · 11 August 2026Ayati DevicesRs 15 crorediabetic foot diagnostic technologiesayatidevices.com ↗

Ayati Devices raises ₹15 crore in pre-series a funding led by Inflexor Ventures

By · Editor ·

Pre-Series AFounded 2019
  • Ayati Devices builds portable, affordable diagnostic tools for diabetic foot complications and vascular disease
  • The company raised ₹15 crore in a pre-series a round led by Inflexor Ventures to scale its diagnostic platform and expand globally
  • Ayati's technologies are already deployed in over 30 countries and have regulatory clearances in India, the U.S; europe, and other markets

What happened

  • Ayati Devices, a Bengaluru-based medical technology company, raised ₹15 crore in a pre-series A funding round led by Inflexor Ventures.
  • Ayati's portfolio includes products like Vibrasense, Vasosense, Angiocam, and the PODIA Trolley, which provide portable, point-of-care diagnostics for diabetic foot complications and vascular disease.
  • The company has deployed over 10,000 devices across 30+ countries and has regulatory clearances in India, the U.S., Europe, and other international markets.
  • Ayati's technologies are designed to bring advanced diagnostics to primary care centres and clinics, reducing the need for specialist facilities.

Why it matters

  • India's medical devices sector is growing rapidly, driven by innovation and government incentives, and Ayati is positioned to benefit from this trend.
  • Diabetic foot complications are a major health issue, with over 90 million Indians living with diabetes and 50,000 lower-limb amputations occurring annually in India.
  • Ayati's diagnostic tools are clinically validated and have been tested in studies showing high sensitivity and specificity for detecting peripheral neuropathy.

The business

  • Ayati Devices focuses on developing portable, point-of-care diagnostic tools for diabetic foot complications and vascular disease.
  • The company's products include Vibrasense for nerve function assessment, Vasosense for vascular screening, Angiocam for tissue perfusion imaging, and the PODIA Trolley for pay-per-test screening.
  • Ayati's technologies are designed to be used in clinics, hospitals, and screening programs, making advanced diagnostics more accessible and affordable.
  • The company has deployed over 10,000 devices across 30+ countries and has regulatory clearances in India, the U.S., Europe, and other international markets.
  • Ayati's solutions are used by healthcare providers, including clinics, hospitals, and specialists such as diabetologists and podiatrists.

The founders

Nishant Kathpal

Founder & CEO
in
  • Founded Ayati Devices in 2019 with a focus on diabetic foot diagnostics.
  • Incubated at IIT Bombay's SINE (Society for Innovation and Entrepreneurship).

Who put in money

  • Inflexor Ventures lead — A venture capital firm focused on early-stage technology and healthcare startups.

In numbers

10,000+devices deployed · 2026
30+countries with deployments · 2026
90 milliondiabetic population in India · 2026
50,000annual amputations in India · 2026

What happens next

  • Ayati plans to expand its manufacturing capacity and strengthen its distribution network in India and overseas.
  • The company aims to develop AI capabilities that integrate data from multiple diagnostic tests for risk stratification and clinical decision support.
  • Ayati will evaluate direct commercial operations in key international markets as demand for its diagnostic tools grows.

Earlier rounds

  • 2026-08-11 · pre-series a · ₹15 Crore · led by Inflexor Ventures

Up against

Other medical device companies focused on diabetic foot diagnostics and vascular assessment.

In their words

“Diabetic foot remains one of the most overlooked healthcare challenges, despite being largely preventable with timely screening.”Nishant Kathpal, Founder & CEO, Ayati Devices
“Ayati is a platform play in the medical devices sector and exactly the kind of company Inflexor exists to back.”Pratip Mazumdar, Partner, Inflexor Ventures

Words to know

point-of-care diagnostics
Medical tests and treatments provided at or near the patient's location, rather than in a laboratory or specialist facility.
peripheral artery disease
A condition in which narrowed arteries reduce blood flow to the limbs, often causing pain and increasing the risk of amputation.
neuropathy
Damage to the nerves that can cause pain, numbness, or weakness, often associated with diabetes.
microcirculation
The flow of blood through the smallest blood vessels in the body, which is crucial for tissue health and healing.

The numbers around it

Healthcare & Life Sciences in August 2026: 10 rounds with a disclosed amount, $139 million in all; the biggest was Biodeal Pharmaceuticals (₹385 crore). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Pre-Series A: A pre-Series A round is money raised after a seed round and before a full Series A, so that a startup can reach the revenue, growth and retention Series A investors expect. In India such rounds commonly run from about ₹5 crore to ₹40 crore, and the label itself is informal.
  • Series A: Series A is usually the first large round a startup raises from venture capital funds, after it has shown that people want what it sells. In India it commonly runs from a few million dollars to about $15 million, or roughly ₹25 crore to over ₹100 crore, with founders selling about 15 to 25 percent, as of November 2026.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

All startup news on 11 August 2026 →

Is this Ayati Devices? Get your “Featured on StopDown” badge →